Physician profile
Anthony N Gregory
NPI 1396734513
$2,176.08
in general payments reported to CMS, 2019-2025
11 companies · $952 in 2025
The $952 reported for 2025 was more than what a typical Dermatology provider received nationally (typical 2025 total: $772).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $35.87 · 2021: $83.30 · 2023: $319 · 2024: $786 · 2025: $952.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,039 · Education: $18.10.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,038.81 |
| Education | $18.10 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $814.24 | 2023-2025 | |
| Novartis Pharmaceuticals Corporation | $573.71 | 2024-2025 | |
| Regeneron Healthcare Solutions, INC. | $210.14 | 2024-2025 | Libtayo, Dupixent |
| Janssen Biotech, INC. | $140.26 | 2021-2025 | Tremfya, Simponi, Simponi Aria |
| Lilly USA, LLC | $133.22 | 2023-2025 | Olumiant, Ebglyss, Taltz |
| E.R. Squibb & Sons, L.L.C. | $130.07 | 2023 | Sotyktu |
| Amgen INC. | $73.32 | 2023-2025 | Otezla, Otezla |
| Misonix INC | $35.87 | 2020 | |
| Ucb, INC. | $35.53 | 2024 | Bimzelx |
| Sun Pharmaceutical Industries INC. | $18.42 | 2025 | |
| Strata Skin Sciences, INC. | $11.30 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Anthony Gregory listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.